Literature DB >> 20171954

High dose of ascorbic acid induces cell death in mesothelioma cells.

Yukitoshi Takemura1, Motohiko Satoh, Kiyotoshi Satoh, Hironobu Hamada, Yoshitaka Sekido, Shunichiro Kubota.   

Abstract

Malignant mesothelioma is an asbestos-related fatal disease with no effective cure. Recently, high dose of ascorbate in cancer treatment has been reexamined. We studied whether high dose of ascorbic acid induced cell death of four human mesothelioma cell lines. High dose of ascorbic acid induced cell death of all mesothelioma cell lines in a dose-dependent manner. We further clarified the cell killing mechanism that ascorbic acid induced reactive oxygen species and impaired mitochondrial membrane potential. In vivo experiment, intravenous administration of ascorbic acid significantly decreased the growth rate of mesothelioma tumor inoculated in mice. These data suggest that ascorbic acid may have benefits for patients with mesothelioma. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171954     DOI: 10.1016/j.bbrc.2010.02.012

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

Review 1.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

Review 2.  A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Ludmil Benov
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

3.  The unfolded protein response controls endoplasmic reticulum stress-induced apoptosis of MCF-7 cells via a high dose of vitamin C treatment.

Authors:  Peter Bober; Zuzana Tomková; Michal Alexovič; Ivan Ropovik; Ján Sabo
Journal:  Mol Biol Rep       Date:  2019-01-29       Impact factor: 2.316

4.  Combined effects of retinol, ascorbic acid and α-tocopherol on diurnal variations in rectal temperature of Black Harco pullets subjected to heat stress.

Authors:  Victor Olusegun Sinkalu; Joseph Olusegun Ayo
Journal:  Int J Biometeorol       Date:  2016-06-16       Impact factor: 3.787

Review 5.  Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.

Authors:  Nermi L Parrow; Jonathan A Leshin; Mark Levine
Journal:  Antioxid Redox Signal       Date:  2013-06-19       Impact factor: 8.401

6.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

Review 7.  Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.

Authors:  Mark Levine; Sebastian J Padayatty; Michael Graham Espey
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

8.  Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.

Authors:  Michael Graham Espey; Ping Chen; Brian Chalmers; Jeanne Drisko; Andrew Y Sun; Mark Levine; Qi Chen
Journal:  Free Radic Biol Med       Date:  2011-03-12       Impact factor: 7.376

9.  Vitamin C Cytotoxicity and Its Effects in Redox Homeostasis and Energetic Metabolism in Papillary Thyroid Carcinoma Cell Lines.

Authors:  Laura Tronci; Gabriele Serreli; Cristina Piras; Daniela Virginia Frau; Tinuccia Dettori; Monica Deiana; Federica Murgia; Maria Laura Santoru; Martina Spada; Vera Piera Leoni; Julian Leether Griffin; Roberta Vanni; Luigi Atzori; Paola Caria
Journal:  Antioxidants (Basel)       Date:  2021-05-20

10.  Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy.

Authors:  Min Zhou; Xin Li; Yuanyuan Li; Qiu'e Yao; Yue Ming; Ziwei Li; Laichun Lu; Sanjun Shi
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.